The largest database of trusted experimental protocols

6 protocols using epr21794

1

CD47 Expression Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD47 immunohistochemical staining was performed with 4 µm thick sectioned slides from TMA blocks. The Ventana BenchMark XT autostainer (Ventana Medical Systems, Tucson, AZ, USA) was used according to the manufacturer’s protocol. Anti-CD47 monoclonal antibody (1:200 dilution, EPR21794; Abcam, Cambridge, UK) was used to detect CD47 expression.
+ Open protocol
+ Expand
2

Imaging CD47, CXCR4, TLR4, and RAGE in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
2x104 MM cells were seeded on glass coverslips and the following day treated overnight with either BoxA (400 nM) or CXCL12 (10 nM) and PBS (control). Following treatment, cells were fixed with 4% paraformaldehyde in PHEM buffer for 10 min at RT, washed twice with 1% BSA in PBS for 5 min, and then blocked with 4% BSA and 10% goat serum in PBS. Cells were overlayed with the primary antibodies:
rabbit monoclonal anti‐CD47 (1:100, EPR21794, Abcam #AB218810); mouse monoclonal anti‐CD47 (1:50, B6H12, Santa Cruz #sc12730) either alone or in combination or goat polyclonal anti‐CXCR4 (1:100, Abcam #AB1670), or rabbit monoclonal anti‐TLR4 (1:50, Cell signaling #14358) and or rabbit polyclonal anti‐RAGE (1:100, Invitrogen #PA1‐075) for 1 h at room temperature. Following three washes with 0.2% BSA in PBS, the cells were incubated with secondary antibodies in 0.2% BSA/PBS + 10% goat serum and incubated for 45 min at RT. For nuclei staining, 1 µg/ml Hoechst 33358 was used. For cytosol detection, Phalloidin FITC (P5282, Sigma‐Aldrich) was used.
Secondary probes (Duolink, Sigma‐Aldrich) for PLA reaction were as follows: Anti‐Rabbit MINUS (#DUO92005), Anti‐Rabbit PLUS (#DUO92002), Anti‐Goat MINUS (#DUO92006), and Anti‐Goat PLUS (#DUO92003). When both primary antibodies were used, the PLA products were obtained by using the Anti‐Rabbit PLUS and Anti‐Goat MINUS probes.
+ Open protocol
+ Expand
3

Tissue Microarray Preparation and CD47 IHC

Check if the same lab product or an alternative is used in the 5 most similar protocols
We constructed tissue microarrays (TMA) to efficiently evaluate biomarker expression [17 (link)]. Manual microarray systems (Tissue Microarray Set, Labro, Seoul, Korea) and formalin-fixed paraffin-embedded tissues were used for tissue microarray (TMA) construction. We selected a representative area of the tumor by light microscopy and collected tissue cores (3.0 mm) from the corresponding donor block. Then, the tissue cores were transferred to a recipient block consisting of 6 × 5 samples. Each TMA block was cut into 4-μm-thick sections and stored at −70 to −80 °C.
IHC was used to evaluate CD47 expression in tissue samples of produced TMA. According to the manufacturer’s protocol, we performed IHC with the Benchmark XT automated staining system (Ventana Medical Systems, Tucson, AZ, USA), and a recombinant anti-CD47 antibody (EPR21794, Abcam, Cambridge, UK; diluted 1:200) was used as a primary antibody.
+ Open protocol
+ Expand
4

CD47 Immunohistochemical Staining in TMA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining of CD47 was performed with 4-µm-thick sections from TMA blocks using the Ventana Benchmark XT automated staining system (Ventana Medical Systems, Tucson, AZ, USA) according to the manufacturer’s protocol. Anti-CD47 rabbit monoclonal antibody (Abcam, Cambridge, UK, EPR21794) was used with a dilution factor of 1:200.
+ Open protocol
+ Expand
5

Quantifying TSP1 and CD47 Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mixture of TSP1 and rh-CD47p, with or without the monoclonal TSP1 antibody (mAb 301221, Novus Biologicals, Littleton, CO, USA), was prepared in a cell-free setting and incubated at 37 °C for 45–60 min. Upon incubation, TSP1 and rh-CD47p mixture samples were subject to electrophoresis on gradient 4–20% Mini-PROTEAN TGX precast gels (BioRad, Hercules, CA, USA) for approximately 1 h at 200 V, followed by transfer to a nitrocellulose membrane (BioRad, Hercules, CA, USA) at 4 °C with a constant current of 150 mA for 2 h. Membranes treated with Odyssey blocking buffer (LI-COR, Lincoln, NE, USA) at room temperature for 1 h were exposed to a primary antibody against TSP1 (A6.1, Abcam, Cambridge, MA, USA, 1:500) at 4 °C overnight and subsequent incubation with a red-fluorescence-labeled secondary antibody (926-68050, LI-COR, Biosciences, Lincoln, NE, USA, 1:10,000) at room temperature for 1 h. Membranes were reprobed with a primary antibody against rh-CD47p (EPR21794, Abcam, Cambridge, MA, USA, 1:500) at 4 °C overnight and a green-fluorescence-labeled secondary antibody (926-32213, LI-COR, 1:10,000) at room temperature for 1 h. Images were captured by an Odyssey CLx imagining system (LI-COR, Biosciences, Lincoln, NE, USA).
+ Open protocol
+ Expand
6

Profiling Immune Markers in Cancer Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) of PD‐L1, CD47, CD8 and cluster of differentiation 68 (CD68) was performed on tissue microarrays (TMAs). The tissues were obtained by surgery and embedded in paraffin. We took two 2‐mm cores from each sample to constitute the TMAs, and then 4‐μm thick TMA sections were manufactured. We incubated the TMAs with the primary antibodies against CD47 (EPR21794, Abcam), PD‐L1 (28‐8, Abcam), CD68 (KP1, Abcam) and CD8 (D8A8Y, CST), and then with the secondary antibodies and 3, 3′‐diaminobenzidine (DAB). Two independent pathologists, who were blinded to the clinical information, examined the results of the IHC. Membranous tumor proportion score (TPS) was applied to score the PD‐L1 and CD47 expression. PD‐L1 and CD47 positive were defined as TPS ≥ 1% and TPS ≥ 5%, respectively. PD‐L1/CD47 co‐expression was defined as PD‐L1 positive and CD47 positive. We counted the number of CD8‐positive tumor‐infiltrating lymphocytes (TILs) and CD68‐positive macrophages in six high‐power fields and calculated the average for each case. With the median count as the cut‐off value, we divided the density of CD8‐positive TILs and the density of CD68‐positive macrophages into high and low groups.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!